- Global Operation
- Contract Manufacturing
Indarol® Easycap is a long-acting β2 agonist. When inhaled it acts locally in the lung as a bronchodilator. It binds to β2 receptors on the smooth muscle cells that surround the airways causing the muscle cells to relax and opening the airways. The pharmacological effects of Indacaterol as a β2 receptors agonist drug is to stimulation of intracellular enzyme adenyl cyclase, which catalyzes the conversion of ATP to cAMP, intracellularly. Increase cAMP levels cause relaxation of Bronchial smooth muscle.
Indarol® Easycap is indicated for the treatment of airflow obstruction in patients with chronic obstructive pulmonary diseases (COPD), including chronic bronchitis and/or emphysema.
Indarol® 150 Easycap: Each box contains 30 capsules in Alu-PVDC blister strips. Each
Indarol® 150 Easycap capsule contains Indacaterol Maleate INN equivalent to 150 mcg Indacaterol.
Indarol® 300 Easycap: Each box contains 30 capsules in Alu-PVDC blister strips. Each
Indarol® 300 Easycap capsule contains Indacaterol Maleate INN equivalent to 300 mcg Indacaterol.